rs397516333
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_000260.4(MYO7A):c.6577C>T(p.Leu2193Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000014 in 1,432,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
MYO7A
NM_000260.4 missense
NM_000260.4 missense
Scores
12
6
1
Clinical Significance
Conservation
PhyloP100: 5.81
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.873
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.6577C>T | p.Leu2193Phe | missense_variant | 49/49 | ENST00000409709.9 | NP_000251.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.6577C>T | p.Leu2193Phe | missense_variant | 49/49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.6457C>T | p.Leu2153Phe | missense_variant | 49/49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.6430C>T | p.Leu2144Phe | missense_variant | 50/50 | 1 | ENSP00000386635.2 | |||
MYO7A | ENST00000458169.2 | c.4003C>T | p.Leu1335Phe | missense_variant | 29/29 | 1 | ENSP00000417017.2 | |||
MYO7A | ENST00000670577.1 | n.*1149C>T | non_coding_transcript_exon_variant | 32/32 | ENSP00000499323.1 | |||||
MYO7A | ENST00000670577.1 | n.*1149C>T | 3_prime_UTR_variant | 32/32 | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000140 AC: 2AN: 1432822Hom.: 0 Cov.: 30 AF XY: 0.00000141 AC XY: 1AN XY: 709628
GnomAD4 exome
AF:
AC:
2
AN:
1432822
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
709628
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 08, 2011 | Variant classified as Uncertain Significance - Favor Pathogenic. The Leu2193Phe variant in MYO7A has not been reported in the literature nor previously identifi ed by our laboratory. This residue is conserved across species and computational analyses (PolyPhen2, SIFT) suggest that the Leu2193Phe variant may impact the p rotein. However, this information is not predictive enough to assume pathogenici ty. It should be noted that this lab has only sequenced the MYO7A in 20 Asian pr obands and no Asian healthy controls. In addition, healthy control information i s unavailable from either public databases or scientific literature, such that t he full spectrum of benign variation has not yet been defined for this populatio n. Future analysis could reveal that the Leu2193Phe variant is common in this po pulation and therefore unlikely to be pathogenic. However, the presence of this variant in combination with another pathogenic variant in this gene, increases t he likelihood that this variant is pathogenic if found to be in trans (on separa te copies of the gene). In summary, the clinical significance of this variant ca nnot be determined with certainty at this time; however, we would lean towards a more likely pathogenic role. - |
Usher syndrome type 1B Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 21, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;.;.;D
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D
Sift4G
Uncertain
D;D;D;D
Polyphen
D;.;.;.
Vest4
MutPred
Loss of stability (P = 0.0863);.;.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at